Your browser doesn't support javascript.
loading
A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer.
Boukovala, Myrto; Spetsieris, Nicholas; Weldon, Justin A; Tsikkinis, Alexandros; Hoang, Anh; Aparicio, Ana; Tu, Shi-Ming; Araujo, John C; Zurita, Amado J; Corn, Paul G; Pagliaro, Lance; Kim, Jeri; Wang, Jennifer; Subudhi, Sumit K; Tannir, Nizar M; Logothetis, Christopher J; Troncoso, Patricia; Wen, Sijin; Efstathiou, Eleni.
Afiliación
  • Boukovala M; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Spetsieris N; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Weldon JA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Tsikkinis A; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Hoang A; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Aparicio A; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Tu SM; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Araujo JC; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Zurita AJ; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Corn PG; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Pagliaro L; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Kim J; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Wang J; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Subudhi SK; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Tannir NM; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Logothetis CJ; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Troncoso P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wen S; Department of Biostatistics, West Virginia University School of Public Health, Morgantown, WV, USA.
  • Efstathiou E; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA. Electronic address: eefstathiou@mdanderson.org.
Eur J Cancer ; 127: 67-75, 2020 03.
Article en En | MEDLINE | ID: mdl-31986451

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores Androgénicos / Biomarcadores de Tumor / Neoplasias de la Próstata Resistentes a la Castración / Acetato de Abiraterona / Antagonistas de Andrógenos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores Androgénicos / Biomarcadores de Tumor / Neoplasias de la Próstata Resistentes a la Castración / Acetato de Abiraterona / Antagonistas de Andrógenos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos